Allergan PLC’s Irvine-based business lines were key contributors to fourth-quarter revenue of $3.86 billion, up 7% year-over-year.
Allergan is chartered in Dublin, Ireland, and maintains U.S. headquarters in Parsippany, N.J. Its Irvine campus includes aesthetic medicine and therapeutics, along with eye care, a grouping that makes up the company’s U.S. Specialized Therapeutics segment. The unit had double-digit growth and $1.2 billion in revenue.
The Irvine units appear to have outpaced others, helping the company’s shares continue a recent rise, to a market cap of about $92 billion as of last week.
Top performing brands during the quarter included Botox; Restasis, an eye drop treatment for dry eyes; dermal fillers; and Ozurdex, an eye implant used to treat noninfectious eye inflammation and diabetic macular edema. Other strong performers were Linzess/Constella, which treats chronic constipation, and birth control pill Lo Loestrin.
Allergan’s eye care business reported $660.1 million in revenue, Restasis accounting for $393.1 million, or about 60%. Botox, its key product, continued to deliver strong growth in facial cosmetic and therapeutics. Botox cosmetic and therapeutic revenue were at $199.4 million and $313.5 million, respectively.
Product launches accounted for $90 million of revenue. Kybella, an injectable treatment for double chin, contributed $12 million.
Medtech
The Advance Manufacturing Expo & Conference concluded its annual event featuring 2,200 exhibiting suppliers, including approximately 150 Orange County-based companies.
The Feb. 7 to Feb. 9 event, held at the Anaheim Convention Center, was put together by Santa Monica-based UBM Americas, featuring a wide range of suppliers, including those in plastics, packaging, medical device manufacturing, automation and robotics. It’s the largest med-tech design and manufacturing event in North America.
UBM provides marketing and events services, including for the fashion, technology, healthcare and advanced manufacturing industries.
Patient Day
Edwards Lifesciences Corp. celebrated its annual patient day on Feb. 9 at the company’s headquarters in Irvine.
The medical device maker, which develops treatments for structural heart disease, brings heart valve patients from around the country to meet each other and Edwards employees who made their valves.
About 30 patients attended this year, a slightly smaller group compared to the typical 50 patients due to lack of space. Edwards’ new facility is under construction, according to a company spokesperson, who said the patient event should be back to its normal size next year.
Bits & Pieces
San Clemente-based Glaukos Corp. appointed Joseph Gilliam chief financial officer and senior vice president of corporate development, effective later this year. He previously served as managing director of healthcare investment banking at JPMorgan Chase and will replace Richard Harrison, who’s retiring. … Newport Beach-based Hoag Memorial Hospital Presbyterian received a Women’s Choice Award recognizing it as one of America’s best hospitals for heart care and obstetrics, care and surgery relating to childbirth. It’s the fourth consecutive year Hoag has been honored. Hoag is part of St. Joseph Hoag Health healthcare system. … The Hydration Room, with locations in Newport Beach, Laguna Beach and Huntington Beach, plans to open three more locations in Orange County, Los Angeles, and/or San Diego by the second quarter. The vitamin intravenous and injection therapy clinic has approximately $2.5 million annual revenue and 22 employees.
